DCC

Hazard statements (CLP)

H312, H315, H317, H318, H336, H351

Code

Statements

H312

Harmful in contact with skin

SECTION 2: Hazards identification

Regulation (EC) No. 1272/2008 Classification of the substance or mixture

Signal word

Danger Danger

Hazard statements

H312 Harmful in contact with skin. H315 Causes skin irritation. H317 May cause an allergic skin reaction. H318 Causes serious eye damage. H336 May cause drowsiness or dizziness. H351 Suspected of causing cancer. H317 May cause an allergic skin reaction. H351 Suspected of causing cancer. H318 Causes serious eye damage.

Precautionary statements

P202 Do not handle until all safety precautions have been read and understood. P261 Avoid breathing mist or vapours. P280 Wear protective gloves/ protective clothing/ eye protection/ face protection. P202 Do not handle until all safety precautions have been read and understood. P261 Avoid breathing mist or vapours. P280 Wear protective gloves/ protective clothing/ eye protection/ face protection. P305 + P351 + P338 IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. P308 + P313 IF exposed or concerned: Get medical advice/ attention.

Response

P302 + P352 + P312 IF ON SKIN: Wash with plenty of water. Call a POISON CENTER/ doctor if you feel unwell. P305 + P351 + P338 IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. P308 + P313 IF exposed or concerned: Get medical advice/ attention.

Hazardous Ingredients

Dichloromethane N,N'-dicyclohexylcarbodiimide Reduced Labelling (<= 125 ml)

Supplemental label elements

none

2.3 Other hazards

This substance/mixture contains no components considered to be either persistent, bioaccumulative and toxic (PBT), or very persistent and very bioaccumulative (vPvB) at levels of 0.1% or higher.

ECOLOGICAL INFORMATION

The substance/mixture does not contain components considered to have endocrine disrupting properties according to REACH Article 57(f) or Commission Delegated regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at levels of 0.1% or higher.

TOXICOLOGICAL INFORMATION

The substance/mixture does not contain components considered to have endocrine disrupting properties according to REACH Article 57(f) or Commission Delegated regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at levels of 0.1% or higher.

2.1 Classification of the substance or mixture

Classification (REGULATION (EC) No 1272/2008) Acute toxicity, Category 4 H312: Harmful in contact with skin. Skin irritation, Category 2 H315: Causes skin irritation. Serious eye damage, Category 1 H318: Causes serious eye damage. Skin sensitisation, Category 1 H317: May cause an allergic skin reaction. Carcinogenicity, Category 2 H351: Suspected of causing cancer. Specific target organ toxicity - H336: May cause drowsiness or dizziness. single exposure, Category 3, Central nervous system